Isfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran.
BMC Ophthalmol. 2023 Feb 10;23(1):58. doi: 10.1186/s12886-023-02806-7.
Thyroid-eye disease (TED) is the most common extra-thyroidal presentation of graves' disease. We performed this study to compare clinical characteristics of TED in hypothyroid vs. hyperthyroid patients.
This was a retrospective analytical cross-sectional study in which we compared demographics, severity (EUGOGO classification) and activity (clinical activity score) of TED, thyroid disease duration, TED duration and clinical signs between hypothyroid eye disease (Ho-TED) and hyperthyroid eye disease (Hr-TED). To minimize the effect of selection bias and potential confounders, 1:1 propensity score matching (PSM) was also performed.
Three hundred and seventy-four patients (341 Hr-TED and 33 Ho-TED) with a female to male ratio of 1.4:1 were identified in our study. Female to male ratio was 1.3:1 in hyperthyroid and 4.5:1 in hypothyroid group (P = 0.005). The duration of thyroid disease was longer in Ho-TED (P = 0.002) while the duration of eye disease was not significantly different between the Hr-TED (mean = 24.33 ± 41.69, median = 8) and Ho-TED (mean = 19.06 ± 33.60, median = 12) (P = 0.923). Most of the patients in hypothyroid group developed eye involvement after thyroid disease (80.0% in hypo vs. 48.1% in hyper, P = 0.003). Severity (P = 0.13) and activity (P = 0.11) was not different between Hr-TED and Ho-TED patients. After PSM analysis, no clinical characteristics were significantly different between the two groups (P > 0.05).
The results of our study showed several differences between the Hr/Ho TED patients including sex, duration of thyroid disease and pattern of eye involvement. After matching the two groups with statistical methods, no clinical characteristics were different between Hr-TED and Ho-TED patients.
甲状腺眼病(TED)是格雷夫斯病最常见的甲状腺外表现。我们进行这项研究是为了比较甲状腺功能减退与甲状腺功能亢进患者的 TED 临床特征。
这是一项回顾性分析性横断面研究,我们比较了甲状腺功能减退性眼病(Ho-TED)和甲状腺功能亢进性眼病(Hr-TED)患者的人口统计学特征、严重程度(EUGOGO 分类)和活动度(临床活动评分)、甲状腺疾病病程、TED 病程和临床体征。为了最小化选择偏倚和潜在混杂因素的影响,还进行了 1:1 倾向评分匹配(PSM)。
我们的研究共纳入了 374 例患者(341 例 Hr-TED 和 33 例 Ho-TED),男女比例为 1.4:1。甲状腺功能亢进组男女比例为 1.3:1,甲状腺功能减退组为 4.5:1(P=0.005)。Ho-TED 患者的甲状腺疾病病程较长(P=0.002),而 Hr-TED 和 Ho-TED 患者的眼病病程无显著差异(平均=24.33±41.69,中位数=8;平均=19.06±33.60,中位数=12)(P=0.923)。大多数甲状腺功能减退组患者在甲状腺疾病后出现眼部受累(80.0%在甲减组 vs. 48.1%在甲亢组,P=0.003)。Hr-TED 和 Ho-TED 患者的严重程度(P=0.13)和活动度(P=0.11)无差异。PSM 分析后,两组间无临床特征存在显著差异(P>0.05)。
我们的研究结果显示,Hr/Ho TED 患者存在多种差异,包括性别、甲状腺疾病病程和眼部受累模式。通过统计学方法匹配两组后,Hr-TED 和 Ho-TED 患者的临床特征无差异。